• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

January 2005: Additions and Deletions to the Drug Product List

24th Edition: Cumulative Supplement Number 1

[Prescription - OTC]

NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.5 CUMULATIVE SUPPLEMENT LEGEND.



ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST
      ACETIC ACID, GLACIAL
          SOLUTION/DROPS; OTIC
            ACETIC ACID
>D>   AT      MORTON GROVE               2%                                      N40166 001  Jul 26, 1996    Jan  CRLD
>A>   AT  +                              2%                                      N40166 001  Jul 26, 1996    Jan  CRLD
>D>         VOSOL
>D>   AT  +   MEDPOINTE PHARM            2%                                      N12179 001                  Jan  DISC
>A>         @                            2%                                      N12179 001                  Jan  DISC


        ALBUTEROL SULFATE
          SOLUTION; INHALATION
            ALBUTEROL SULFATE
>D>   AN      DEY                        EQ 0.083% BASE                          N72652 001  Feb 21, 1992    Jan  CRLD
>A>   AN  +                              EQ 0.083% BASE                          N72652 001  Feb 21, 1992    Jan  CRLD


        ALPRAZOLAM
>A>       TABLET, ORALLY DISINTEGRATING; ORAL
>A>         NIRAVAM
>A>           SCHWARZ PHARMA             0.25MG                                  N21726 001  Jan 19, 2005    Jan  NEWA
>A>                                      0.5MG                                   N21726 002  Jan 19, 2005    Jan  NEWA
>A>                                      1MG                                     N21726 003  Jan 19, 2005    Jan  NEWA
>A>       +                              2MG                                     N21726 004  Jan 19, 2005    Jan  NEWA


        AMOXICILLIN; CLAVULANATE POTASSIUM
          FOR SUSPENSION; ORAL
            AMOXICILLIN AND CLAVULANATE POTASSIUM
>A>   AB      HIKMA PHARMS               200MG/5ML;EQ 28.5MG BASE/5ML            N65191 002  Jan 25, 2005    Jan  NEWA
>A>   AB                                 400MG/5ML;EQ 57MG BASE/5ML              N65191 001  Jan 25, 2005    Jan  NEWA
          TABLET, CHEWABLE; ORAL
            AMOXICILLIN AND CLAVULANATE POTASSIUM
>A>   AB      TEVA                       200MG;EQ 28.5MG BASE                    N65205 001  Feb 09, 2005    Jan  NEWA
>A>   AB                                 400MG;EQ 57MG BASE                      N65205 002  Feb 09, 2005    Jan  NEWA


        AMPICILLIN SODIUM
          INJECTABLE; INJECTION
            AMPICILLIN SODIUM
>D>         @ IBI                        EQ 125MG BASE/VIAL                      N62797 001  Jul 12, 1993    Jan  CMFD
>D>   AP                                 EQ 2GM BASE/VIAL                        N62797 002  Jul 12, 1993    Jan  CAHN
>A>   AP      INSTITUTO                  EQ 125MG BASE/VIAL                      N62797 001  Jul 12, 1993    Jan  CMFD
>A>   AP                                 EQ 2GM BASE/VIAL                        N62797 002  Jul 12, 1993    Jan  CAHN


        ATTABLET; ORAL

>A>   AB    ATZYDUS PHARMS USA           25MG                                    N76900 001  Jan 28, 2005    Jan  NEWA

>A>   AB                                 50MG                                    N76900 002  Jan 28, 2005    Jan  NEWA
>A>   AB                                 100MG                                   N76900 003  Jan 28, 2005    Jan  NEWA

        BETAMETHASONE DIPROPIONATE
          OINTMENT; TOPICAL
>D>         ALPHATREX
>D>   AB      SAVAGE LABS                EQ 0.05% BASE                           N19143 001  Sep 04, 1984    Jan  DISC
>A>         @                            EQ 0.05% BASE                           N19143 001  Sep 04, 1984    Jan  DISC


        CEPHALEXIN
          CAPSULE; ORAL
            CEPHALEXIN
>A>   AB      BELCHER                    EQ 250MG BASE                           N62713 001  Jul 15, 1988    Jan  CAHN
>A>   AB                                 EQ 500MG BASE                           N62713 002  Jul 15, 1988    Jan  CAHN
>D>   AB      LABS ATRAL                 EQ 250MG BASE                           N62713 001  Jul 15, 1988    Jan  CAHN
>D>   AB                                 EQ 500MG BASE                           N62713 002  Jul 15, 1988    Jan  CAHN
>D>   AB      MJ PHARMS                  EQ 250MG BASE                           N62791 001  Jun 11, 1987    Jan  CAHN
>D>   AB                                 EQ 500MG BASE                           N62791 002  Jun 11, 1987    Jan  CAHN
>A>   AB      SUN PHARM INDS (IN)        EQ 250MG BASE                           N62791 001  Jun 11, 1987    Jan  CAHN
>A>   AB                                 EQ 500MG BASE                           N62791 002  Jun 11, 1987    Jan  CAHN

        CIPROFLOXACIN HYDROCHLORIDE
          SOLUTION/DROPS; OPHTHALMIC
            CIPROFLOXACIN
>A>   AT      HITECH PHARMA              EQ 0.3% BASE                            N76673 001  Jan 21, 2005    Jan  NEWA
          TABLET; ORAL
            CIPROFLOXACIN
>A>   AB      COBALT                     EQ 100MG BASE                           N76794 001  Feb 10, 2005    Jan  NEWA

>A>   AB      TARO                       EQ 100MG BASE                           N76912 001  Feb 18, 2005    Jan  NEWA

        CITALOPRAM HYDROBROMIDE
          TABLET; ORAL
            CITALOPRAM HYDROBROMIDE
>A>   AB      MYLAN                      EQ 10MG BASE                            N77039 001  Feb 03, 2005    Jan  NEWA
>A>   AB                                 EQ 20MG BASE                            N77039 002  Feb 03, 2005    Jan  NEWA
>A>   AB                                 EQ 40MG BASE                            N77039 003  Feb 03, 2005    Jan  NEWA


        CLARITHROMYCIN
          TABLET, EXTENDED RELEASE; ORAL
>A>         CLARITHROMYCIN
>A>           RANBAXY                    1GM                                     N65210 001  Jan 26, 2005    Jan  NEWA

        CLINDAMYCIN HYDROCHLORIDE
          CAPSULE; ORAL
            CLINDAMYCIN HYDROCHLORIDE
>A>   AB      ZYDUS PHARMS USA           EQ 75MG BASE                            N65217 001  Jan 31, 2005    Jan  NEWA

>A>   AB                                 EQ 150MG BASE                           N65217 002  Jan 31, 2005    Jan  NEWA
>A>   AB                                 EQ 300MG BASE                           N65217 003  Jan 31, 2005    Jan  NEWA

        CYANOCOBALAMIN
>A>       SPRAY, METERED; NASAL
>A>         NASCOBAL
>A>       +   NASTECH PHARM              0.5MG/SPRAY                             N21642 001  Jan 31, 2005    Jan  NEWA


        DALTEPARIN SODIUM
          INJECTABLE; INJECTION
            FRAGMIN
>A>       +   PHARMACIA AND              7,500 IU/0.3ML                          N20287 005  Apr 04, 2002    Jan  NEWA

        DESMOPRESSIN ACETATE
          SPRAY, METERED; NASAL
            DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION)
>A>   AB      APOTEX                     0.01MG/SPRAY                            N76703 001  Jan 27, 2005    Jan  NEWA


        ERYTHROMYCIN
          SOLUTION; TOPICAL
            ERYMAX
>D>   AT      ALLERGAN                   2%                                      N62508 002  Jul 11, 1985    Jan  CAHN
>A>   AT      MERZ PHARMS                2%                                      N62508 002  Jul 11, 1985    Jan  CAHN

        ESOMEPRAZOLE MAGNESIUM
          CAPSULE, DELAYED REL PELLETS; ORAL
            NEXIUM
>D>       +   ASTRAZENECA                EQ 20MG BASE                            N21153 001  Feb 20, 2001    Jan  CRLD
>A>                                      EQ 20MG BASE                            N21153 001  Feb 20, 2001    Jan  CRLD

        ESTRADIOL
          FILM, EXTENDED RELEASE; TRANSDERMAL
            CLIMARA
>D>   BX  +   BERLEX                     0.025MG/24HR                            N20375 004  Mar 05, 1999    Jan  CFTG
>A>   AB2 +                              0.025MG/24HR                            N20375 004  Mar 05, 1999    Jan  CFTG
>D>   BX  +                              0.075MG/24HR                            N20375 003  Mar 23, 1998    Jan  CFTG
>A>   AB2 +                              0.075MG/24HR                            N20375 003  Mar 23, 1998    Jan  CFTG
>D>         ESCLIM
>D>   BX      WOMEN FIRST                0.025MG/24HR                            N20847 001  Aug 04, 1998    Jan  DISC
>A>         @                            0.025MG/24HR                            N20847 001  Aug 04, 1998    Jan  DISC
>D>   BX                                 0.0375MG/24HR                           N20847 002  Aug 04, 1998    Jan  DISC
>A>         @                            0.0375MG/24HR                           N20847 002  Aug 04, 1998    Jan  DISC
>D>   BX      WOMEN FIRST                0.05MG/24HR                             N20847 003  Aug 04, 1998    Jan  DISC
>A>         @                            0.05MG/24HR                             N20847 003  Aug 04, 1998    Jan  DISC
>D>   BX                                 0.075MG/24HR                            N20847 004  Aug 04, 1998    Jan  DISC
>A>         @                            0.075MG/24HR                            N20847 004  Aug 04, 1998    Jan  DISC
>D>   BX                                 0.1MG/24HR                              N20847 005  Aug 04, 1998    Jan  DISC
>A>         @                            0.1MG/24HR                              N20847 005  Aug 04, 1998    Jan  DISC

            ESTRADIOL
>A>   AB2     MYLAN                      0.025MG/24HR                            N75182 003  Jan 26, 2005    Jan  NEWA
>A>   AB2                                0.075MG/24HR                            N75182 002  Jan 26, 2005    Jan  NEWA
            VIVELLE
>D>   AB1 +   NOVARTIS                   0.025MG/24HR                            N20323 005  Aug 16, 2000    Jan  DISC
>A>         @                            0.025MG/24HR                            N20323 005  Aug 16, 2000    Jan  DISC
>D>   AB1 +                              0.05MG/24HR                             N20323 002  Oct 28, 1994    Jan  CRLD
>A>   AB1                                0.05MG/24HR                             N20323 002  Oct 28, 1994    Jan  CRLD
>D>   AB1 +                              0.1MG/24HR                              N20323 004  Oct 28, 1994    Jan  CRLD
>A>   AB1                                0.1MG/24HR                              N20323 004  Oct 28, 1994    Jan  CRLD
            VIVELLE-DOT
>D>   AB1     NOVARTIS                   0.025MG/24HR                            N20538 009  May 03, 2002    Jan  CRLD
>A>   BX  +                              0.025MG/24HR                            N20538 009  May 03, 2002    Jan  CRLD
>D>   BX                                 0.0375MG/24HR                           N20538 005  Jan 08, 1999    Jan  CRLD
>A>   BX  +                              0.0375MG/24HR                           N20538 005  Jan 08, 1999    Jan  CRLD
>D>   AB1                                0.05MG/24HR                             N20538 006  Jan 08, 1999    Jan  CRLD
>A>   AB1 +                              0.05MG/24HR                             N20538 006  Jan 08, 1999    Jan  CRLD
>D>   BX                                 0.075MG/24HR                            N20538 007  Jan 08, 1999    Jan  CRLD
>A>   BX  +                              0.075MG/24HR                            N20538 007  Jan 08, 1999    Jan  CRLD
>D>   AB1                                0.1MG/24HR                              N20538 008  Jan 08, 1999    Jan  CRLD
>A>   AB1 +                              0.1MG/24HR                              N20538 008  Jan 08, 1999    Jan  CRLD


        FENOLDOPAM MESYLATE
          INJECTABLE; INJECTION
            FENOLDOPAM MESYLATE
>A>   AP      SABEX 2002                 EQ 10MG BASE/ML                         N77155 001  Feb 15, 2005    Jan  NEWA

        FENTANYL
          FILM, EXTENDED RELEASE; TRANSDERMAL
            DURAGESIC
>D>       +   ALZA                       0.6MG/24HR                              N19813 004  Aug 07, 1990    Jan  CFTG
>D>                                      1.2MG/24HR                              N19813 003  Aug 07, 1990    Jan  CFTG
>D>                                      1.8MG/24HR                              N19813 002  Aug 07, 1990    Jan  CFTG
>D>                                      2.4MG/24HR                              N19813 001  Aug 07, 1990    Jan  CFTG
            DURAGESIC-100
>A>   AB      ALZA                       100UGM/HR                               N19813 001  Aug 07, 1990    Jan  CFTG
            DURAGESIC-25
>A>   AB  +   ALZA                       25UGM/HR                                N19813 004  Aug 07, 1990    Jan  CFTG
            DURAGESIC-50
>A>   AB      ALZA                       50UGM/HR                                N19813 003  Aug 07, 1990    Jan  CFTG
            DURAGESIC-75
>A>   AB      ALZA                       75UGM/HR                                N19813 002  Aug 07, 1990    Jan  CFTG
>A>         FENTANYL
>A>   AB      MYLAN                      25UGM/HR                                N76258 001  Jan 28, 2005    Jan  NEWA
>A>   AB                                 50UGM/HR                                N76258 002  Jan 28, 2005    Jan  NEWA
>A>   AB                                 75UGM/HR                                N76258 003  Jan 28, 2005    Jan  NEWA
>A>   AB                                 100UGM/HR                               N76258 004  Jan 28, 2005    Jan  NEWA

        FLUTICASONE PROPIONATE
          AEROSOL, METERED; INHALATION
            FLOVENT
>D>           GLAXOSMITHKLINE            0.044MG/INH                             N20548 001  Mar 27, 1996    Jan  CRLD
>A>       +                              0.044MG/INH                             N20548 001  Mar 27, 1996    Jan  CRLD
>D>                                      0.11MG/INH                              N20548 002  Mar 27, 1996    Jan  CRLD
>A>       +                              0.11MG/INH                              N20548 002  Mar 27, 1996    Jan  CRLD
            FLOVENT HFA
>D>           GLAXOSMITHKLINE            0.044MG/INH                             N21433 003  May 14, 2004    Jan  CRLD
>A>       +                              0.044MG/INH                             N21433 003  May 14, 2004    Jan  CRLD
>D>                                      0.11MG/INH                              N21433 002  May 14, 2004    Jan  CRLD
>A>       +                              0.11MG/INH                              N21433 002  May 14, 2004    Jan  CRLD


        FOLLITROPIN ALFA/BETA
          INJECTABLE; SUBCUTANEOUS
            FOLLISTIM AQ

>D>           ORGANON USA INC            300 IU/0.525ML                          N21211 001  Mar 23, 2004    Jan  CPOT
>A>       +                              300 IU/0.36ML                           N21211 001  Mar 23, 2004    Jan  CPOT
>D>       +                              600 IU/0.885ML                          N21211 002  Mar 23, 2004    Jan  CPOT
>A>       +                              600 IU/0.72ML                           N21211 002  Mar 23, 2004    Jan  CPOT


        GALANTAMINE HYDROBROMIDE
          CAPSULE, EXTENDED RELEASE; ORAL
            REMINYL
>D>           JOHNSON AND                EQ 8MG BASE                             N21615 001  Dec 22, 2004    Jan  CRLD
>A>       +                              EQ 8MG BASE                             N21615 001  Dec 22, 2004    Jan  CRLD
>D>       +                              EQ 24MG BASE                            N21615 003  Dec 22, 2004    Jan  CRLD
>A>                                      EQ 24MG BASE                            N21615 003  Dec 22, 2004    Jan  CRLD


        GLYBURIDE; METFORMIN HYDROCHLORIDE
          TABLET; ORAL
            GLYBURIDE AND METFORMIN HCL
>A>   AB      TEVA                       1.25MG;250MG                            N76821 001  Jan 27, 2005    Jan  NEWA
>A>   AB                                 2.5MG;500MG                             N76821 002  Jan 27, 2005    Jan  NEWA
>A>   AB                                 5MG;500MG                               N76821 003  Jan 27, 2005    Jan  NEWA

        HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
          SYRUP; ORAL
            HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
>D>   AA      AXIOM PHARM                1.5MG/5ML;5MG/5ML                       N40285 001  Jul 19, 1999    Jan  CAHN
>A>   AA      IVAX PHARMS                1.5MG/5ML;5MG/5ML                       N40285 001  Jul 19, 1999    Jan  CAHN

        LEUPROLIDE ACETATE
          INJECTABLE; SUBCUTANEOUS
            ELIGARD
>D>       +   ATRIX                      22.5MG/VIAL                             N21379 001  Jul 24, 2002    Jan  CAHN
>A>       +   QLT USA                    22.5MG/VIAL                             N21379 001  Jul 24, 2002    Jan  CAHN


        LEVOFLOXACIN
          TABLET; ORAL
            LEVAQUIN
>D>       +   ORTHO MCNEIL               750MG                                   N20634 003  Sep 08, 2000    Jan  CFTG
>A>   AB  +                              750MG                                   N20634 003  Sep 08, 2000    Jan  CFTG
>A>         LEVOFLOXACIN
>A>   AB      TEVA                       750MG                                   N76361 003  Jan 26, 2005    Jan  NEWA

        LORAZEPAM

          SOLORAZEPAM

>D>         @ ROXANE                     0.5MG/5ML                               N74648 001  Mar 18, 1997    Jan  CMFD
>A>                                      0.5MG/5ML                               N74648 001  Mar 18, 1997    Jan  CMFD

>D>     MANGAFODIPIR TRISODIUM
>D>       INJECTABLE; INJECTION
>D>         TESLASCAN
>D>       +   GE HEALTHCARE              37.9MG/ML                               N20652 001  Nov 26, 1997    Jan  DISC
>A>         @                            37.9MG/ML                               N20652 001  Nov 26, 1997    Jan  DISC


        METHYLDOPA
          TABLET; ORAL
>D>         ALDOMET
>D>   AB  +   MERCK                      500MG                                   N13400 002                  Jan  DISC
>A>         @                            500MG                                   N13400 002                  Jan  DISC
            METHYLDOPA
>D>   AB      MYLAN                      500MG                                   N70076 001  Apr 18, 1985    Jan  CRLD
>A>   AB  +                              500MG                                   N70076 001  Apr 18, 1985    Jan  CRLD


        METHYLDOPATE HYDROCHLORIDE
          INJECTABLE; INJECTION
>D>         ALDOMET
>D>   AP  +   MERCK                      50MG/ML                                 N13401 001                  Jan  DISC
>A>         @                            50MG/ML                                 N13401 001                  Jan  DISC
            METHYLDOPATE HCL
>D>   AP      LUITPOLD                   50MG/ML                                 N71279 001  Oct 02, 1987    Jan  CRLD
>A>   AP  +                              50MG/ML                                 N71279 001  Oct 02, 1987    Jan  CRLD
        METHYLERGONOVINE MALEATE


          TABLET; ORAL
            METHERGINE
>D>           NOVARTIS                   0.2MG                                   N06035 003                  Jan  CRLD
>A>       +                              0.2MG                                   N06035 003                  Jan  CRLD

        MIDAZOLAM HYDROCHLORIDE
          INJECTABLE; INJECTION
            MIDAZOLAM HCL
>A>   AP      INTL MEDICATED             EQ 1MG BASE/ML                          N76144 001  Jan 26, 2005    Jan  NEWA
>A>   AP                                 EQ 5MG BASE/ML                          N76144 002  Jan 26, 2005    Jan  NEWA


        MOMETASONE FUROATE
          CREAM; TOPICAL
            ELOCON
>D>       +   SCHERING                   0.1%                                    N19625 001  May 06, 1987    Jan  CFTG
>A>   AB  +                              0.1%                                    N19625 001  May 06, 1987    Jan  CFTG
>A>         MOMETASONE FUROATE
>A>   AB      TARO                       0.1%                                    N76679 001  Dec 21, 2004    Jan  NEWA


        OXALIPLATIN
          INJECTABLE; IV (INFUSION)
            ELOXATIN
>A>       +   SANOFI                     50MG/10ML (5MG/ML)                      N21759 001  Jan 31, 2005    Jan  NEWA
>A>       +                              100MG/20ML (5MG/ML)                     N21759 002  Jan 31, 2005    Jan  NEWA

        PACLITAXEL
>A>       FOR SUSPENSION; IV (INFUSION)
>A>         ABRAXANE
>A>       +   AM BIOSCIENCE              100MG/VIAL                              N21660 001  Jan 07, 2005    Jan  NEWA


        PENTOBARBITAL SODIUM
>D>       CAPSULE; ORAL
>D>         SODIUM PENTOBARBITAL
>D>       +   VALEANT PHARM              100MG                                   N83264 001                  Jan  DISC
>A>         @                            100MG                                   N83264 001                  Jan  DISC


        POTASSIUM CITRATE
          TABLET, EXTENDED RELEASE; ORAL
>D>         POTASSIUM CITRATE
>D>           MISSION PHARMA             5MEQ                                    N19071 001  Aug 30, 1985    Jan  CTNA
>D>       +                              10MEQ                                   N19071 002  Aug 31, 1992    Jan  CTNA
>A>         UROCIT-K
>A>           MISSION PHARMA             5MEQ                                    N19071 001  Aug 30, 1985    Jan  CTNA
>A>       +                              10MEQ                                   N19071 002  Aug 31, 1992    Jan  CTNA


        PREDNISOLONE
          SYRUP; ORAL
            PREDNISOLONE
>D>   AA      AXIOM PHARM                15MG/5ML                                N40287 001  May 28, 1999    Jan  CAHN
>A>   AA      IVAX PHARMS                15MG/5ML                                N40287 001  May 28, 1999    Jan  CAHN

        PROMETHAZINE HYDROCHLORIDE
          TABLET; ORAL
            PROMETHAZINE HCL
>D>   AB      ABLE                       12.5MG                                  N40558 001  Jul 01, 2004    Jan  CTEC
>A>                                      12.5MG                                  N40558 001  Jul 01, 2004    Jan  CTEC


        QUINAPRIL HYDROCHLORIDE
          TABLET; ORAL
            QUINAPRIL HCL
>A>   AB      PAR PHARM                  EQ 5MG BASE                             N76036 001  Jan 28, 2005    Jan  NEWA
>A>   AB                                 EQ 10MG BASE                            N76036 002  Jan 28, 2005    Jan  NEWA
>A>   AB                                 EQ 20MG BASE                            N76036 003  Jan 28, 2005    Jan  NEWA
>A>   AB                                 EQ 40MG BASE                            N76036 004  Jan 28, 2005    Jan  NEWA


        SULFAMETHOXAZOLE; TRIMETHOPRIM
          TABLET; ORAL
            SULFAMETHOXAZOLE AND TRIMETHOPRIM
>A>   AB      INTERPHARM                 400MG;80MG                              N76899 001  Jan 27, 2005    Jan  NEWA
>A>   AB      INTERPHARM                 800MG;160MG                             N76899 002  Jan 27, 2005    Jan  NEWA

        TACROLIMUS
          CAPSULE; ORAL
            PROGRAF
>D>           FUJISAWA                   EQ 1MG BASE                             N50708 001  Apr 08, 1994    Jan  CRLD
>A>       +                              EQ 1MG BASE                             N50708 001  Apr 08, 1994    Jan  CRLD


        TERCONAZOLE
          CREAM; VAGINAL
            TERCONAZOLE
>A>   AB      ALTANA                     0.4%                                    N76712 001  Feb 18, 2005    Jan  NEWA

        TESTOSTERONE CYPIONATE
          INJECTABLE; INJECTION
            TESTOSTERONE CYPIONATE
>A>   AO      PADDOCK                    200MG/ML                                N40530 001  Jan 31, 2005    Jan  NEWA


        TOREMIFENE CITRATE
          TABLET; ORAL
            FARESTON
>A>       +   GTX INC                    EQ 60MG BASE                            N20497 001  May 29, 1997    Jan  CAHN
>D>       +   ORION                      EQ 60MG BASE                            N20497 001  May 29, 1997    Jan  CAHN

        TRIMETHOPRIM HYDROCHLORIDE
          SOLUTION; ORAL
            PRIMSOL
>D>         @ ASCENT PEDS                EQ 25MG BASE/5ML                        N74374 001  Jun 23, 1995    Jan  CAHN
>D>       +                              EQ 50MG BASE/5ML                        N74973 001  Jan 24, 2000    Jan  CAHN
>A>         @ TARO PHARMS NORTH          EQ 25MG BASE/5ML                        N74374 001  Jun 23, 1995    Jan  CAHN
>A>       +                              EQ 50MG BASE/5ML                        N74973 001  Jan 24, 2000    Jan  CAHN



ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

     LORATADINE
          SYRUP; ORAL
>D>         CLARITIN HIVES RELIEF
>D>       +   SCHERING                   1MG/ML                                  N20641 003  Nov 19, 2003    Jan  DISC
>A>         @                            1MG/ML                                  N20641 003  Nov 19, 2003    Jan  DISC

 

 
-